All SARS-CoV-2 articles – Page 7
-
NewsWearing a face mask in public spaces cuts risk of common respiratory symptoms, study suggests
Wearing a surgical face mask in public spaces reduces the risk of self-reported respiratory symptoms, finds a trial of adults in Norway.
-
NewsSARS-CoV-2 pandemic increases maternal deaths from non-respiratory causes, study finds
A new study revealed a significant impact of the COVID-19 pandemic on maternal mortality in Chile. The pandemic did not affect direct obstetric deaths such as hemorrhage, sepsis and abortion, but non-respiratory indirect obstetric causes increased the most.
-
NewsNirmatrelvir/ritonavir antiviral combination shows potential in reducing COVID-19 hospitalizations
A systematic review aimed to summarize published evidence on the efficacy, effectiveness, and safety of nirmatrelvir/ritonavir for COVID-19. The review also intended to assess the robustness of the evidence from randomized controlled trials.
-
NewsMutations of the spike gene do not predict the severity of variants of SARS-CoV-2
The two recent and prevalent strains of the virus that cause COVID-19 are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a higher number of mutations.
-
NewsScientists investigate effectiveness of non-pharmaceutical interventions against pathogens
Scientists have investigated the success of non-pharmaceutical interventions, analysing almost two million SARS-CoV-2 genomes that occurred in the German population during the years of the pandemic.
-
NewsNew ECDC Director Pamela Rendi-Wagner emphasises importance of restoring public trust in science after pandemic
Incoming ECDC Director Dr Pamela Rendi Wagner has outlined her vision for the agency, highlighting the challenges to public health after the COVID-19 pandemic, including war in Europe, climate change, and increasing social inequalities.
-
NewsStudy identifies unpredicted immune responses to adenoviral COVID vaccines
Researchers have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
-
NewsWhite paper explores innovative approaches to vaccine trials and pandemic preparedness
An international consortium of experts has created a white paper on innovative approaches for clinical vaccine research in order to be better prepared for future pandemics.
-
NewsStudy identifies protein that helps COVID-19 virus evade immune system
Discovery of a new viral evasion mechanism, and of a monoclonal antibody that subverts it, is an advance in immunotherapy that offers the prospect of effective host-directed treatment to combat infections.
-
NewsScientists prioritize 6 key pathogens for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games
French health authority researchers have identified priority pathogens that could be suitable for wastewater surveillance (WWS) during the Paris 2024 Olympic and Paralympic Games taking place from 26 July to 11 August and 28 August to 8 September.
-
NewsReinfections from the virus that causes COVID-19 likely have similar severity to original infection
Researchers have found that severe infections from the virus that causes COVID-19 tend to foreshadow similar severity of infection the next time a person contracts the disease.
-
NewsNew bio-based tool quickly detects concerning coronavirus variants
Researchers have developed a bioelectric device that can detect and classify new variants of coronavirus to identify those that are most harmful. It has the potential to do the same with other viruses, as well.
-
NewsResearchers develop predictive model for cross-border COVID spread
A study on the spread of infections across Nordic borders from spring until the end of 2020 sheds light on the efficacy of cross-border travel restrictions, helping to better understand which measures actually make a difference.
-
NewsScientists uncover molecular basis of how potential anti-Covid drug binds to viral N-glycan
Researchers evaluating the potential of naturally occurring pradimicin A (PRM-A) as a new anti-SARS-CoV-2 drug that suppresses SARS-CoV-2 transmission investigated how exactly PRM-A binds to the viral N-glycans.
-
NewsCancer drug could be repurposed to fight Covid-19
Twelve years ago, cancer researchers identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that the same molecule does the same thing in lung tissue infected with COVID-19.
-
NewsScientists unravel life-saving effect of dexamethasone in COVID-19
Researchers have discovered how the cortisone compound dexamethasone influences the impaired inflammatory response to Covid-19 and which patients benefit from it.
-
NewsRegular vaccine boosts may help people who are immunocompromised fight Covid-19
New research finds booster doses of bivalent vaccines given every three to six months helps maintain a person’s ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5.
-
NewsCOVID-19 pandemic tied to low birth weight for infants in India
The incidence of low birth weight rose sharply in India amid the COVID-19 pandemic, according to new research.
-
NewsRecombinHunt: predicting new pandemics through data analysis
A study presents the promising results of RecombinHunt, a new data-driven method which can identify, with high accuracy and computational efficiency, recombinant SARS-CoV-2 genomes with one or two breakpoints.
-
NewsScientists ID novel host factors that facilitates SARS-CoV-2 entry
Researchers have identified new host factors that interact with the receptor binding domain of the SARS-CoV-2 spike protein to promote viral entry.